Kazuya Isobe

Suggest Changes
Learn More
BACKGROUND Although therapeutic angiogenesis is a most promising strategy for the treatment of myocardial infarction (MI), it remains unknown if and how endogenous angiogenesis inhibitors, such as(More)
  • 1